I take my hat off to all who are still holding this dog and respect your resilience but "hope" is not enough to build a sustainable business. Dunover is correct and I am surprised everyone's sentiment is to "hold" or "buy". This is not a public company's backside.
I have kept watching to see whether the Chartered Accountant and Co could use their "expertise" to rebuild from the ashes with the possibility of re-entering the fray. But, as per earlier posts, this was just another opportunity for them to use M&A's etc to make themselves $$$ and my suspicions were correct.
I felt embarrassed when I sold at circa 4c as I knew within myself I should have sold many months prior but when Maria finally left, I was hoping they would get someone who knew what to do. Maybe CA's should stick to just counting retrospective numbers....
- Forums
- ASX - By Stock
- AN1
- Ann: H1 FY24 Results and Corporate Update
Ann: H1 FY24 Results and Corporate Update, page-12
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online